FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297267231> ?p ?o ?g. }

• W4297267231 endingPage "678" @default.
• W4297267231 startingPage "665" @default.
• W4297267231 abstract "Objectives of this study, as part of a nation-wide HIV pre-exposure prophylaxis (PrEP) evaluation project, were to determine the incidence of infections with HIV, chlamydia, gonorrhea, syphilis, hepatitis A/B/C in persons using PrEP, and to describe the health care funded PrEP use in Germany. Additionally, factors associated with chlamydia/gonorrhea and syphilis infections were assessed.Anonymous data of PrEP users were collected at 47 HIV-specialty centers from 09/2019-12/2020. Incidence rates were calculated per 100 person years (py). Using longitudinal mixed models, we analyzed risk factors associated with sexually transmitted infections (STIs).4620 PrEP users were included: 99.2% male, median age 38 years (IQR 32-45), 98.6% men who have sex with men (MSM). The median duration of PrEP exposure was 451 days (IQR 357-488), totaling 5132 py. Four HIV infections were diagnosed, incidence rate 0,078/100py (95% CI 0.029-0.208). For two, suboptimal adherence was reported and in the third case, suboptimal adherence and resistance to emtricitabine were observed. One infection was likely acquired before PrEP start. Incidence rates were 21.6/100py for chlamydia, 23.7/100py for gonorrhea, 10.1/100py for syphilis and 55.4/100py for any STI and decreased significantly during the observation period. 65.5% of syphilis, 55.6% of chlamydia and 50.1% of gonorrhea cases were detected by screening of asymptomatic individuals. In a multivariable analysis among MSM younger age, PrEP start before health insurance coverage and daily PrEP were associated with greater risk for chlamydia/gonorrhea. Symptom triggered testing and a history of STI were associated with a higher risk for chlamydia/gonorrhea and syphilis. A significantly lower risk for chlamydia/gonorrhea and syphilis was found for observations during the COVID-19 pandemic period.We found that HIV-PrEP is almost exclusively used by MSM in Germany. A very low incidence of HIV infection and decreasing incidence rates of STIs were found in this cohort of PrEP users. The results were influenced by the SARS-CoV-2 pandemic. Rollout of PrEP covered by health insurance should be continued to prevent HIV infections. Increased PrEP availability to people at risk of HIV infection through the elimination of barriers requires further attention. Investigation and monitoring with a longer follow-up would be of value." @default.
• W4297267231 created "2022-09-28" @default.
• W4297267231 creator A5000517630 @default.
• W4297267231 creator A5001172469 @default.
• W4297267231 creator A5001359223 @default.
• W4297267231 creator A5004088234 @default.
• W4297267231 creator A5004946541 @default.
• W4297267231 creator A5006076157 @default.
• W4297267231 creator A5006799640 @default.
• W4297267231 creator A5007420809 @default.
• W4297267231 creator A5009244143 @default.
• W4297267231 creator A5009297445 @default.
• W4297267231 creator A5009815686 @default.
• W4297267231 creator A5010652005 @default.
• W4297267231 creator A5012718946 @default.
• W4297267231 creator A5014380024 @default.
• W4297267231 creator A5015471237 @default.
• W4297267231 creator A5016362071 @default.
• W4297267231 creator A5016727630 @default.
• W4297267231 creator A5016775060 @default.
• W4297267231 creator A5017868088 @default.
• W4297267231 creator A5018127354 @default.
• W4297267231 creator A5018563090 @default.
• W4297267231 creator A5020158980 @default.
• W4297267231 creator A5020671503 @default.
• W4297267231 creator A5021184946 @default.
• W4297267231 creator A5021922684 @default.
• W4297267231 creator A5022334321 @default.
• W4297267231 creator A5022403726 @default.
• W4297267231 creator A5022924215 @default.
• W4297267231 creator A5023617671 @default.
• W4297267231 creator A5023896848 @default.
• W4297267231 creator A5024265680 @default.
• W4297267231 creator A5025113978 @default.
• W4297267231 creator A5027606787 @default.
• W4297267231 creator A5027902901 @default.
• W4297267231 creator A5027941446 @default.
• W4297267231 creator A5028152811 @default.
• W4297267231 creator A5028859696 @default.
• W4297267231 creator A5029468111 @default.
• W4297267231 creator A5029582159 @default.
• W4297267231 creator A5029968821 @default.
• W4297267231 creator A5030183793 @default.
• W4297267231 creator A5030984772 @default.
• W4297267231 creator A5031238109 @default.
• W4297267231 creator A5034446029 @default.
• W4297267231 creator A5034873990 @default.
• W4297267231 creator A5036208925 @default.
• W4297267231 creator A5038816648 @default.
• W4297267231 creator A5041390477 @default.
• W4297267231 creator A5041601934 @default.
• W4297267231 creator A5041777861 @default.
• W4297267231 creator A5042333779 @default.
• W4297267231 creator A5042524381 @default.
• W4297267231 creator A5044473093 @default.
• W4297267231 creator A5044921310 @default.
• W4297267231 creator A5046867296 @default.
• W4297267231 creator A5047613373 @default.
• W4297267231 creator A5047626680 @default.
• W4297267231 creator A5048491954 @default.
• W4297267231 creator A5052143824 @default.
• W4297267231 creator A5052567585 @default.
• W4297267231 creator A5054063339 @default.
• W4297267231 creator A5055331025 @default.
• W4297267231 creator A5055406105 @default.
• W4297267231 creator A5055530457 @default.
• W4297267231 creator A5055767005 @default.
• W4297267231 creator A5057293076 @default.
• W4297267231 creator A5061336544 @default.
• W4297267231 creator A5062155386 @default.
• W4297267231 creator A5062483535 @default.
• W4297267231 creator A5063319886 @default.
• W4297267231 creator A5064338075 @default.
• W4297267231 creator A5064401100 @default.
• W4297267231 creator A5065638135 @default.
• W4297267231 creator A5066745396 @default.
• W4297267231 creator A5068377020 @default.
• W4297267231 creator A5069716339 @default.
• W4297267231 creator A5071357308 @default.
• W4297267231 creator A5073074465 @default.
• W4297267231 creator A5078121291 @default.
• W4297267231 creator A5078682228 @default.
• W4297267231 creator A5078705813 @default.
• W4297267231 creator A5078767364 @default.
• W4297267231 creator A5078808048 @default.
• W4297267231 creator A5079616242 @default.
• W4297267231 creator A5079810297 @default.
• W4297267231 creator A5083303274 @default.
• W4297267231 creator A5086920897 @default.
• W4297267231 creator A5087090005 @default.
• W4297267231 creator A5087716130 @default.
• W4297267231 creator A5088854368 @default.
• W4297267231 creator A5089479735 @default.
• W4297267231 creator A5073015904 @default.
• W4297267231 date "2022-09-27" @default.
• W4297267231 modified "2023-10-13" @default.
• W4297267231 title "Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany" @default.
• W4297267231 cites W1413161224 @default.

• next